SCHEMBL4765028

SCHEMBL4765028

CC(C)OC(=O)Nc1cccc(C2CCN(CCCNC(=O)C(c3ccc(F)cc3)c3ccc(F)cc3)CC2)c1

nearest known ligand 0.81

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ADRA1D P25100 1/20 0.57
ADRA1A P35348 1/20 0.57
ADRA1B P35368 1/20 0.57
MCHR1 Q99705 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5508122 0.93 ADRA1D (0.68) ADRA1DADRA1AADRA1B
SCHEMBL4794082 0.93 ADRA1D (0.62) ADRA1DADRA1AADRA1B
SCHEMBL4775315 0.92 DRD2 (0.57) ADRA1DADRA1AADRA1BMCHR1
SCHEMBL5511357 0.90 MCHR1 (0.62) ADRA1DADRA1AADRA1BMCHR1
SCHEMBL5515598 0.89 ADRA1D (0.62) ADRA1DADRA1AADRA1BMCHR1
SCHEMBL5511778 0.87 ADRA1D (0.60) ADRA1DADRA1AADRA1BMCHR1
SCHEMBL5515372 0.87 ADRA1D (0.59) ADRA1DADRA1AADRA1BMCHR1
SCHEMBL5511193 0.86 MCHR1 (0.60) ADRA1DADRA1AADRA1BMCHR1
SCHEMBL4791321 0.86 ADRA1D (0.57) ADRA1DADRA1AADRA1B
SCHEMBL5508531 0.86 ADRA1D (0.58) ADRA1DADRA1AADRA1BMCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1590326-A4 SUBSTITUTED ALKYL AMIDO PIPERIDINES LUNDBECK & CO AS H (DK) 2008-04-30 EP disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-20060217418-A1 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2006-09-28 US disclosed
US-7105544-B2 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2006-09-12 US disclosed
US-20060084649-A9 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2006-04-20 US disclosed
US-20060041139-A9 SUBSTITUTED ALKYL AMIDO PIPERIDINES H. LUNDBECK A/S (DK) 2006-02-23 US disclosed
EP-1590326-A2 SUBSTITUTED ALKYL AMIDO PIPERIDINES H. Lundbeck A/S (DK) 2005-11-02 EP disclosed
US-20040186103-A1 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION 2004-09-23 US disclosed
WO-2004064764-A2 SUBSTITUTED ALKYL AMIDO PIPERIDINES H. LUNDBECK A/S (DK) 2004-08-05 WO disclosed
US-20040073036-A1 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073036-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R ADRA1D 45/4885ADRA1A 54/4885ADRA1B 61/4885
US-20060084649-A9 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R ADRA1D 45/4885ADRA1A 54/4885ADRA1B 61/4885
US-20060041139-A9 SUBSTITUTED ALKYL AMIDO PIPERIDINES MCHR1, MCHR2, MC1R ADRA1D 45/4885ADRA1A 54/4885ADRA1B 61/4885
US-20060217418-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R ADRA1D 45/4885ADRA1A 54/4885ADRA1B 61/4885
US-20040186103-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R ADRA1D 45/4885ADRA1A 54/4885ADRA1B 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.